The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Many actions of cyclooxygenase‐2 in cellular dynamics and in cancer
Open accessAbstract
Cyclooxygenase‐2 (COX‐2) is the inducible isoform of cyclooxygenase, the enzyme that catalyzes the rate‐limiting step in prostaglandin synthesis from arachidonic acid. Various prostaglandins are produced in a cell type‐specific manner, and they elicit cellular functions via signaling through G‐protein coupled membrane receptors, and in some cases, through the nuclear receptor PPAR. COX‐2 utilization of arachidonic acid also perturbs the level of intracellular free arachidonic acid and subsequently affects cellular functions. In a number of cell and animal models, induction of COX‐2 has been shown to promote cell growth, inhibit apoptosis and enhance cell motility and adhesion. The mechanisms behind these multiple actions of COX‐2 are largely unknown. Compelling evidence from genetic and clinical studies indicates that COX‐2 upregulation is a key step in carcinogenesis. Overexpression of COX‐2 is sufficient to cause tumorigenesis in animal models and inhibition of the COX‐2 pathway results in reduction in tumor incidence and progression. Therefore, the potential for application of non‐steroidal anti‐inflammatory drugs as well as the recently developed COX‐2 specific inhibitors in cancer clinical practice has drawn tremendous attention in the past few years. Inhibition of COX‐2 promises to be an effective approach in the prevention and treatment of cancer, especially colorectal cancer. J. Cell. Physiol. 190: 279–286, 2002. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
Hockenbery, D. M., Oltvai, Z. N., Yin, X.-M., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80066-n · Cited by 3,419
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., & Dubois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,514
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Tsujii, M., & DuBois, R. N. (1995) · Cell · doi:10.1016/0092-8674(95)90127-2 · Cited by 2,267
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,978
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., & Seibert, K. (2000) · PubMed · Cited by 1,286
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., & Dubois, R. N. (1998) · PubMed · Cited by 1,114
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011
15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C.-H., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004
Jones, M. K., Wang, H., Peskar, B. M., Levin, E., Itani, R. M., Sarfeh, I. J., & Tarnawski, A. S. (1999) · Nature Medicine · doi:10.1038/70995 · Cited by 827
Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice
Liu, C. H., Chang, S.-H., Narko, K., Trifan, O. C., Wu, M.-T., Smith, E., Haudenschild, C., Lane, T. F., & Hla, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010787200 · Cited by 807
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)
Taketo, M. M. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.20.1529 · Cited by 757
Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation
Grilli, M., Pizzi, M., Memo, M., & Spano, P. (1996) · Science · doi:10.1126/science.274.5291.1383 · Cited by 750
Expression of cyclooxygenase-2 in human lung carcinoma.
Wolff, H. J., Saukkonen, K., Anttila, S. L., Karjalainen, A., Vainio, H., & Ristimaki, A. P. (1998) · PubMed · Cited by 717
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D., & DuBois, R. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119400 · Cited by 712
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.
Chan, G. G., Boyle, J. O., Yang, E. K., Zhang, F., Sacks, P. G., Shah, J. P., Edelstein, D. R., Soslow, R. A., Koki, A. T., Woerner, B. M., et al. (1999) · PubMed · Cited by 706
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.
Tucker, O., Dannenberg, A. J., Yang, E. K., Zhang, F., Teng, L., Daly, J. M., Soslow, R. A., Masferrer, J. L., Woerner, B. M., Koki, A. T., et al. (1999) · PubMed · Cited by 692
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677
Hsu, A.-L., Ching, T.-T., Wang, D.-S., Song, X., Rangnekar, V. M., & Chen, C.-S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11397 · Cited by 671
Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells
Sheng, H., Shao, J., Washington, M. K., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009689200 · Cited by 653
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., & Taketo, M. M. (2001) · Nature Medicine · doi:10.1038/nm0901-1048 · Cited by 587
Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis
Chan, T. A., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.681 · Cited by 579
Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C., & Taketo, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4482 · Cited by 559
Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.
Chulada, P. C., Thompson, M. B., Mahler, J. F., Doyle, C. M., Gaul, B. W., Lee, C., Tiano, H. F., Morham, S. G., Smithies, O., & Langenbach, R. J. (2000) · PubMed · Cited by 496
Sulindac Inhibits Activation of the NF-κB Pathway
Yamamoto, Y., Yin, M.-J., Lin, K.-M., & Gaynor, R. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27307 · Cited by 494
Jacoby, R. F., Seibert, K., Cole, C. E., Kelloff, G. J., & Lubet, R. A. (2000) · PubMed · Cited by 478
Otto, J. C., & Smith, W. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.17.9906 · Cited by 462
Reddy, B. S., Hirose, Y., Lubet, R. A., Steele, V. E., Kelloff, G. J., Paulson, S. K., Seibert, K., & Rao, C. V. (2000) · PubMed · Cited by 457
Kutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., & Prescott, S. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4816 · Cited by 449
Self-citationIntracellular unesterified arachidonic acid signals apoptosis
Cao, Y., Pearman, A. T., Zimmerman, G. A., McIntyre, T. M., & Prescott, S. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200367597 · Cited by 437
Self-citationLiu, X., Yao, S., Kirschenbaum, A. M., et al. (1998) · PubMed · Cited by 435
Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
Piazza, G. A., Rahm, A. L. K., Krutzsch, M. F., Sperl, G. J., Paranka, N. S., Gross, P. H., Brendel, K., Burt, R. W., Alberts, D. S., & Pamukcu, R. (1995) · PubMed · Cited by 425
Molina, M. A., Sitjà, M., Lemoine, M. G., Frazier, M. L., & Sinicrope, F. A. (1999) · PubMed · Cited by 404
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part II)
Taketo, M. M. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1609 · Cited by 399
The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis
Gately, S. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026575610124 · Cited by 359
Evans, J. F., Oshima, M., Murai, N., Kargman, S., Arguello, M., Luk, P., Kwong, E., & Taketo, M. M. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02780.x · Cited by 333
Hida, T., Kozaki, K., Muramatsu, H., Masuda, A., Shimizu, S., Mitsudomi, T., Sugiura, T., Ogawa, M., & Takahashi, T. (2000) · PubMed · Cited by 320
Coffey, R. J., Hawkey, C. J., Damstrup, L., Graves-Deal, R., Daniel, V. C., Dempsey, P. J., Chinery, R., Kirkland, S. C., DuBois, R. N., Jetton, T. L., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.657 · Cited by 316
Patent Ductus Arteriosus and Neonatal Death in Prostaglandin Receptor EP4-Deficient Mice
Segi, E., Sugimoto, Y., Yamasaki, A., Aze, Y., Oida, H., Nishimura, T., Murata, T., Matsuoka, T., Ushikubi, F., Hirose, M., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8461 · Cited by 313
Attiga, F. A., Fernández, P. M., Weeraratna, A. T., Manyak, M. J., & Patierno, S. R. (2000) · PubMed · Cited by 310
Souza, R. F., Shewmake, K., Beer, D. G., Cryer, B., & Spechler, S. J. (2000) · PubMed · Cited by 299
Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.
Daniel, T. O., Liu, H., Morrow, J. D., et al. (1999) · PubMed · Cited by 295
Arachidonic Acid Causes Cell Death through the Mitochondrial Permeability Transition
Scorrano, L., Penzo, D., Petronilli, V., Pagano, F., & Bernardi, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010603200 · Cited by 293
Zhang, X., Morham, S. G., Langenbach, R., & Young, D. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.4.451 · Cited by 273
Joki, T., Heese, O., Nikas, D. C., Bello, L., Zhang, J., Kraeft, S., Seyfried, N. T., Abe, T., Chen, L. B., Carroll, R. S., et al. (2000) · PubMed · Cited by 265
Positive and Negative Regulation of NF-κB by COX-2
Poligone, B., & Baldwin, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106599200 · Cited by 263
Regulation of Constitutive Cyclooxygenase-2 Expression in Colon Carcinoma Cells
Shao, J., Sheng, H., Inoue, H., Morrow, J. D., & DuBois, R. N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002324200 · Cited by 257
Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44
Dohadwala, M., Luo, J., Zhu, L., Lin, Y., Dougherty, G. J., Sharma, S., Huang, M., Põld, M., Batra, R. K., & Dubinett, S. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100140200 · Cited by 236
The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure
Stock, J. L., Shinjo, K., Burkhardt, J., Roach, M., Taniguchi, K., Ishikawa, T., Kim, H.-S., Flannery, P. J., Coffman, T. M., McNeish, J. D., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci6749 · Cited by 235
Rozic, J. G., Chakraborty, C., & Lala, P. K. (2001) · International Journal of Cancer · doi:10.1002/ijc.1376 · Cited by 233
Inhibition of Cyclooxygenase: A Novel Approach to Cancer Prevention
Subbaramaiah, K., Zakim, D., Weksler, B. B., & Dannenberg, A. J. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44170 · Cited by 222
Dbaibo, G. S., Obeid, L. M., & Hannun, Y. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46770-6 · Cited by 221
Lu, X., Xie, W., Reed, D., Bradshaw, W. S., & Simmons, D. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7961 · Cited by 206
Neufang, G., Fürstenberger, G., Heidt, M., Marks, F., & Müller-Decker, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121574098 · Cited by 204
Self-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2
Prescott, S. M., & White, R. L. (1996) · Cell · doi:10.1016/s0092-8674(00)81983-2 · Cited by 201
Self-citationChen, W., Wei, S., Liu, J. M., Hsiao, M., Kou‐Lin, J., & Yang, W. K. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200102)9999:9999<894::aid-ijc1146>3.0.co;2-# · Cited by 196
Matsuura, H., Sakaue, M., Subbaramaiah, K., Kamitani, H., Eling, T. E., Dannenberg, A. J., Tanabe, T., Inoue, H., Arata, J., & Jetten, A. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29138 · Cited by 187
Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth
Mann, M., Sheng, H., Shao, J., Williams, C. S., Dubois, R. N., Pisacane, P. I., & Sliwkowski, M. X. (2001) · Gastroenterology · doi:10.1053/gast.2001.24844 · Cited by 179
Higashi, Y., Kanekura, T., & Kanzaki, T. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000601)86:5<667::aid-ijc10>3.0.co;2-y · Cited by 155
Cytochrome P450 Epoxygenase Metabolism of Arachidonic Acid Inhibits Apoptosis
Chen, J., Capdevila, J. H., & Harris, R. C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6322-6331.2001 · Cited by 152
Bornfeldt, K., Campbell, J. S., Koyama, H., Argast, G. M., Leslie, C. C., Raines, E. W., Krebs, E. G., & Ross, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119603 · Cited by 147
Tessner, T. G., Cohn, S. M., Schloemann, S. R., & Stenson, W. F. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70259-8 · Cited by 138
PEA3 Is Up-regulated in Response to Wnt1 and Activates the Expression of Cyclooxygenase-2
Howe, L. R., Crawford, H. C., Subbaramaiah, K., Hassell, J. A., Dannenberg, A. J., & Brown, A. M. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010692200 · Cited by 138
Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration
Rudnick, D. A., Perlmutter, D. H., & Muglia, L. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151217998 · Cited by 137
Handler, J. A., Danilowicz, R. M., & Eling, T. E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39645-0 · Cited by 130
Ding, X., Tong, W., & Adrian, T. E. (2000) · PubMed · Cited by 127
Cao, Y., Traer, E. A., Zimmerman, G. A., et al. (1998) · Genomics · doi:10.1006/geno.1998.5268 · Cited by 126
Self-citationColmenares, M. (2002) · Journal of Biological Chemistry · Cited by 122
Tsuji, S., Kawano, S., Sawaoka, H., Takei, Y., Kobayashi, I., Nagano, K., Fusamoto, H., & Kamada, T. (1996) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90095-2 · Cited by 110
Jiang, M., Liao, C.-F., & Lee, P. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4637 · Cited by 100
Relationship between Arachidonate−Phospholipid Remodeling and Apoptosis
Surette, M. E., Winkler, J. D., Fonteh, A. N., & Chilton, F. H. (1996) · Biochemistry · doi:10.1021/bi9530245 · Cited by 97
Li, M., Wu, X., & Xu, X. (2001) · PubMed · Cited by 96
Prostaglandin E2 stimulates rat and human colonic mucin exocytosis via the EP4 receptor
Belley, A., & Chadee, K. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70285-4 · Cited by 95
Surette, M. E., Fonteh, A. N., Bernatchez, C., & Chilton, F. H. (1999) · Carcinogenesis · doi:10.1093/carcin/20.5.757 · Cited by 90
Belvisi, M. G., Saunders, M., Yacoub, M. H., & Mitchell, J. A. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702104 · Cited by 87
McGinty, A., Chang, Y. E., Sorokin, A., Bokemeyer, D., & Dunn, M. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12095 · Cited by 83
Chang, Y. E., Jakobi, R., McGinty, A., Foschi, M., Dunn, M. J., & Sorokin, A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8571-8579.2000 · Cited by 82
Takafuji, V., Cosme, R., Lublin, D., et al. (2000) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2000.0144 · Cited by 52
Translational Studies on Cox‐2 Inhibitors in the Prevention and Treatment of Colon Cancer
Gupta, R. A., & DuBois, R. N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06709.x · Cited by 42
Fonteh, A. N., LaPorte, T., Swan, D. D., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006551200 · Cited by 31
Kimura, M., Osumi, S., & Ogihara, M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00594-x · Cited by 28
Oncogenic mutant of Gα12 stimulates cell proliferation through cycloxygenase-2 signaling pathway
Dermott, J. M., Reddy, M. R., Onésime, D., Reddy, E. P., & Dhanasekaran, N. (1999) · Oncogene · doi:10.1038/sj.onc.1203345 · Cited by 27
Cited by
Jung, Y.-J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003) · The FASEB Journal · doi:10.1096/fj.03-0329fje · Cited by 679
Bagga, D., Wang, L., Farias-Eisner, R., Glaspy, J. A., & Reddy, S. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0334211100 · Cited by 638
Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies
Tapiero, H., Nguyen Ba, G., Couvreur, P., & Tew, K. D. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00193-2 · Cited by 635
Wang, H., Oo Khor, T., Shu, L., Su, Z.-Y., Fuentes, F., Lee, J.-H., & Tony Kong, A.-N. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012803833026 · Cited by 529
COX-2: A Molecular Target for Colorectal Cancer Prevention
Brown, J. R., & DuBois, R. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.051 · Cited by 444
Metadata
- Authors
- Cao, Y., & Prescott, S. M.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2002-01-24
- Volume
- 190
- Issue
- 3
- Pages
- 279-286
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2045016464
- Cited by
- 464
- References
- 89
- FWCI
- 21.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.